LIVE SESSION BRIEF Drug Manufacturers - General $262B Cap Quant: AVOID NEW MONEY

AstraZeneca PLC (AZN) โ€” Live Session & Technical Brief

Updated Nov 21, 2026 5:53 PM ET ยท Prev Close $175.41

Pro Workspace
Last Session Price
$174.35 -0.60%
-$1.06 vs $175.41 prior close
Intraday Range
$174.04 โ€“ $177.47
Open $176.14
Relative Volume
0.71x Avg
1,996,313 sh
52-Week Range
$153.41 โ€“ $212.71
Benchmark Alpha
+3.04% vs SPY
+5.07% vs QQQ
20-Session Trend +1.3%

Session Regime & Catalyst Assessment

64% Signal Conviction
TECHNICAL 64% Driver Weight

Controlled Session Consolidation (-0.60%) in Drug Manufacturers - General

AstraZeneca PLC (Azn) is trading within a tight intraday band at $174.35 (-0.60%, 0.71x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, AZN is outperforming the S&P 500 by +3.04%. 14-day RSI stands at 44.4, keeping momentum in a bearish regime.

NEWS 70% Weight
AstraZeneca leads European big pharma on growth, pipeline depth

Investing.com -- AstraZeneca PLC Azn is the strongest all-round European big pharma candidate 22.

TECHNICAL 68% Weight
Moving Average Structure: Mixed Alignment

Price ($174.35) trades relative to 20-day SMA ($181.54) and 50-day SMA ($170.71).

Volume Confirmation
LOW VOLUME (0.71x) Consolidation
Sub-average participation โ€” monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 64%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

AZN outperforming the S&P 500 by +3.04%
AZN Session
-0.60%
$174.35
S&P 500 (SPY)
-3.64%
$689.81
Nasdaq 100 (QQQ)
-5.67%
$608.45
Healthcare (XLV)
-0.12%
$177.24
Alpha vs SPY: +3.04% Alpha vs QQQ: +5.07% Alpha vs XLV: -0.48%

Recent AZN Catalyst Headlines

Verified Wire
Why AstraZeneca Could Make Sense Through ETFs Now

Owning AstraZeneca directly means your results lean heavily on what happens to that single business. Simply Wall St highlights that the group has a high level of debt, and that late stage research such as the large trans

Yahoo Finance ยท Nov 19, 2026

1โ€“3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$169.80
Short-term support band
Upper Bound
$178.90
Short-term resistance band
Key Inflection Level
$181.54 (20-day SMA resistance)

Monitor volume expansion above 1.5x RVOL around $181.54 (20-day SMA resistance) for directional breakout confirmation.

Technical Regime (AZN)

MIXED MA TREND
RSI (14)
44.4
Bearish
20-Day SMA
$181.54
Below 20d
50-Day SMA
$170.71
Above 50d
MACD Signal
Bearish
MACD 2.45
ADX (14)
21.9
Moderate trend
10d Momentum
-12.08
Strong downward 10-day pressure

Retail & Crowd Sentiment

Neutral
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Reddit communities: 1 comment (Neutral)

About AstraZeneca PLC

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from โ€ฆ

Sector
Healthcare
Market Cap
$262B
Forward P/E
18.5x
Employees
94,300

Get Instant AZN Catalyst Alerts

Receive an email alert when AZN triggers an unusual volume breakout, options sweep, or rating shift.

AZN Session & Catalyst FAQ

Why is AZN stock trading near flat today?

AstraZeneca PLC (Azn) is trading within a tight intraday band at $174.35 (-0.60%, 0.71x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, AZN is outperforming the S&P 500 by +3.04%. 14-day RSI stands at 44.4, keeping momentum in a bearish regime.

Is AZN stock a buy or sell right now?

Today's session carries a 64% catalyst conviction score on 0.71x relative volume (low participation). Our multi-factor model currently rates AZN as AVOID NEW MONEY. Review full valuation, quality, and timing signals on the AZN Buy or Sell Decision Brief โ†’

What is AZN's intrinsic value and expected trading range?

At $174.35, AZN's modeled 1-to-3 session range is $169.80 โ€“ $178.90, with a key inflection level at $181.54 (20-day SMA resistance). Compare current price against multi-year cash flow projections in the AZN Intrinsic Value & DCF Model โ†’ and Market Cycle Phase Tracker โ†’

What do RSI and moving averages signal for AZN?

RSI at 44.4 reflects soft below-midline momentum. AZN trades at $174.35 relative to its 20-day SMA ($181.54) and 50-day SMA ($170.71), reflecting a mixed moving-average structure.

Tradestie Flagship Research & Market Hubs